Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01602406 |
Title | Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | NLD | ITA | GBR | FRA | ESP | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Novartis Investigative Site | Boston | Massachusetts | 02114 | United States | Details | |
Novartis Investigative Site | Chapel Hill | North Carolina | 27514 | United States | Details | |
Novartis Investigative Site | Philadelphia | Pennsylvania | 19111 | United States | Details | |
Novartis Investigative Site | Wilrijk | 2610 | Belgium | Details | ||
Novartis Investigative Site | Saint Herblain cedex | 44805 | France | Details | ||
Novartis Investigative Site | Milano | MI | 20133 | Italy | Details | |
Novartis Investigative Site | Seoul | Korea | 03080 | Korea, Republic of | Details | |
Novartis Investigative Site | Amsterdam | 1066 CX | Netherlands | Details | ||
Novartis Investigative Site | Valencia | Comunidad Valenciana | 46010 | Spain | Details | |
Novartis Investigative Site | Taipei | 10002 | Taiwan | Details | ||
Novartis Investigative Site | Oxford | OX3 7LJ | United Kingdom | Details |